The Global Plasma Protease C1-Inhibitor Treatment Market Is Estimated To Propelled By The Increasing Demand Of Hereditary Angioedema Treatment Options,
by The global Plasma Protease C1-inhibitor Treatment Market is estimated to be valued at US$ 5432.28 million in 2023 and is expected to exhibit a CAGR of 18% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.